| Dr Michael Alexander Cecilia, DO | |
|
4300 Alton Rd, Miami Beach, FL 33140-2948 | |
| (305) 674-2121 | |
| Not Available |
| Full Name | Dr Michael Alexander Cecilia |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 8 Years |
| Location | 4300 Alton Rd, Miami Beach, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265885354 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | UO5283 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Waterman | Tavares, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Florida Emergency Physicians Kang And Associates Md Inc | 0143113878 | 251 |
News Archive
After an appendectomy, a quarter (24.8%) of all children wanted a stronger pain treatment in the first 24 hours after their operation.
XCELERON, a leader in the field of ultra-sensitive bioanalytical studies supporting clinical research, today announced that it has signed a second Master Service Agreement with GlaxoSmithKline. Under the terms of this agreement, Xceleron will provide analytical support to GlaxoSmithKline and its affiliated research organizations. As part of the deal, Xceleron will increase capacity through the acquisition of an Accelerator Mass Spectrometry (AMS) instrument.
Research from the University of Southampton gives new insight into possible causes of Age-related Macular Degeneration (AMD), a leading cause of vision loss among people aged 50 and older.
Prisons in Maryland have the highest percentage of inmates living with AIDS nationwide, according to a study by the Department of Justice, the Baltimore Sun reports. The study is based on statistics from 41 states at the end of 2005.
Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company announced today initial data for the Phase I dose-escalation clinical trial of SupinoxinTM (RX-5902) initiated in August 2013. This trial was designed to study safety and efficacy in patients with solid cancer tumors.
› Verified 1 days ago
| Entity Name | Inphynet Contracting Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073556767 PECOS PAC ID: 7416865811 Enrollment ID: O20031105000125 |
News Archive
After an appendectomy, a quarter (24.8%) of all children wanted a stronger pain treatment in the first 24 hours after their operation.
XCELERON, a leader in the field of ultra-sensitive bioanalytical studies supporting clinical research, today announced that it has signed a second Master Service Agreement with GlaxoSmithKline. Under the terms of this agreement, Xceleron will provide analytical support to GlaxoSmithKline and its affiliated research organizations. As part of the deal, Xceleron will increase capacity through the acquisition of an Accelerator Mass Spectrometry (AMS) instrument.
Research from the University of Southampton gives new insight into possible causes of Age-related Macular Degeneration (AMD), a leading cause of vision loss among people aged 50 and older.
Prisons in Maryland have the highest percentage of inmates living with AIDS nationwide, according to a study by the Department of Justice, the Baltimore Sun reports. The study is based on statistics from 41 states at the end of 2005.
Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company announced today initial data for the Phase I dose-escalation clinical trial of SupinoxinTM (RX-5902) initiated in August 2013. This trial was designed to study safety and efficacy in patients with solid cancer tumors.
› Verified 1 days ago
| Entity Name | Florida Emergency Physicians Kang And Associates Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811983752 PECOS PAC ID: 0143113878 Enrollment ID: O20040205000687 |
News Archive
After an appendectomy, a quarter (24.8%) of all children wanted a stronger pain treatment in the first 24 hours after their operation.
XCELERON, a leader in the field of ultra-sensitive bioanalytical studies supporting clinical research, today announced that it has signed a second Master Service Agreement with GlaxoSmithKline. Under the terms of this agreement, Xceleron will provide analytical support to GlaxoSmithKline and its affiliated research organizations. As part of the deal, Xceleron will increase capacity through the acquisition of an Accelerator Mass Spectrometry (AMS) instrument.
Research from the University of Southampton gives new insight into possible causes of Age-related Macular Degeneration (AMD), a leading cause of vision loss among people aged 50 and older.
Prisons in Maryland have the highest percentage of inmates living with AIDS nationwide, according to a study by the Department of Justice, the Baltimore Sun reports. The study is based on statistics from 41 states at the end of 2005.
Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company announced today initial data for the Phase I dose-escalation clinical trial of SupinoxinTM (RX-5902) initiated in August 2013. This trial was designed to study safety and efficacy in patients with solid cancer tumors.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Alexander Cecilia, DO 1688 West Ave Apt 405, Miami Beach, FL 33139-2366 Ph: (352) 601-2062 | Dr Michael Alexander Cecilia, DO 4300 Alton Rd, Miami Beach, FL 33140-2948 Ph: (305) 674-2121 |
News Archive
After an appendectomy, a quarter (24.8%) of all children wanted a stronger pain treatment in the first 24 hours after their operation.
XCELERON, a leader in the field of ultra-sensitive bioanalytical studies supporting clinical research, today announced that it has signed a second Master Service Agreement with GlaxoSmithKline. Under the terms of this agreement, Xceleron will provide analytical support to GlaxoSmithKline and its affiliated research organizations. As part of the deal, Xceleron will increase capacity through the acquisition of an Accelerator Mass Spectrometry (AMS) instrument.
Research from the University of Southampton gives new insight into possible causes of Age-related Macular Degeneration (AMD), a leading cause of vision loss among people aged 50 and older.
Prisons in Maryland have the highest percentage of inmates living with AIDS nationwide, according to a study by the Department of Justice, the Baltimore Sun reports. The study is based on statistics from 41 states at the end of 2005.
Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company announced today initial data for the Phase I dose-escalation clinical trial of SupinoxinTM (RX-5902) initiated in August 2013. This trial was designed to study safety and efficacy in patients with solid cancer tumors.
› Verified 1 days ago
Dr. Justin Dana Burkholder, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4300 Alton Rd, Miami Beach, FL 33140 Phone: 610-246-8011 | |
Dr. Nicole Lynn Warren, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4300 Alton Rd, Miami Beach, FL 33140 Phone: 305-674-2828 | |
Dr. Carlos E Cao, MD, MPH Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4300 Alton Rd, Emergency Department, Miami Beach, FL 33140 Phone: 305-674-2121 Fax: 305-535-1811 | |
Dr. Mareril Wheeler, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1504 Bay Rd, Apartment 2910, Miami Beach, FL 33139 Phone: 203-494-1515 | |
Dr. Daniel Aronovich, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4300 Alton Rd, Miami Beach, FL 33140 Phone: 305-674-2121 | |
Dr. Benjamin Lee Boswell, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4300 Alton Rd, Miami Beach, FL 33140 Phone: 305-535-7953 | |
Dr. Robyn Levine, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4300 Alton Rd, Miami Beach, FL 33140 Phone: 305-674-2273 |